Effect of chloroform extract of Gentiana delavayi on APP processing in APP/PS1 CHO cells

Min YANG,Kai-yi ZHOU,Feng-feng LI,Ming YIN,Fu-sheng WANG
2018-01-01
Abstract:Objective: To investigate the influence of chloroform extract of Gentiana delavayi Franch (G. delavayi)on amyloid precursor protein (APP)processing at molecular and cellular levels. Methods: APP/PS1 CHO cells were treated with chloroform extract of G. delavayi of different concentrations (0. 05, 0. 5, 5, 50, 500 μg·L-1)for 24 h. Cell viability of the APP/PS1 CHO cells was measured by MTT assay. Concentrations of Aβ40, Aβ42 and β-site amyloid precursor protein cleaving enzyme 1 (BACE1)in the cell supernatant were determined by using ELISA kit. APP and Aβ degrading enzyme-neprilysin in the cell lysates were analyzed by using Western Blotting. Results: Compared with the control group, when the concentration of chloroform extract of G. delavayi was 50 μg·L-1, the level of Aβ42 was significantly declined(P<0. 01), and the activity of BACE1 was significantly inhibited(P<0. 01 ). Chloroform extract of G. delavayi (500 μg·L-1)reduced the generation of Aβ40 (P <0. 01)and improved the expression of Aβ degrading enzyme-neprilysin (P<0. 01)significantly in the APP/PS1 CHO cells. Conclusion: The chloroform extract of G. delavayi inhibits the generation of β-amyloid, while increasing the expression of Aβ degrading enzyme-neprilysin. The results suggest that the active components of chloroform extract from G. delavayi have the prospect to be developed as anti-AD drugs.
What problem does this paper attempt to address?